Heidelberg Innovation PresseHeidelberg Innovation - einer der führenden deutschen Venture-Capital-Gesellschaften im Bereich der Life Sciences
http://www.hd-innovation.de/en/presse/
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
http://www.hd-innovation.de/en/presse/?id=483
2010-03-10Invendo Medical Files 510(k) Notice with FDA for Clearance of the Computer-Assisted Colonoscopy System
http://www.hd-innovation.de/en/presse/?id=485
2010-03-08mtm laboratories announces the European launch of CINtec® PLUS
http://www.hd-innovation.de/en/presse/?id=486
2010-03-02Santhera Reports Strong 2009 Revenues of CHF 22.3m and is Financed Beyond 2011
http://www.hd-innovation.de/en/presse/?id=481
2010-02-26mtm laboratories: CINtec® p16 Histology test increases accuracy in diagnosing high grade cervical lesions
http://www.hd-innovation.de/en/presse/?id=480
2010-02-26Biofrontera announces that on February 24 it has published the audited annual statement for 2008
http://www.hd-innovation.de/en/presse/?id=478
2010-02-26Detailed phase III results confirm superiority of BF-200 ALA over Metvix
http://www.hd-innovation.de/en/presse/?id=477
2010-01-06invendo medical completes pivotal clinical study
http://www.hd-innovation.de/en/presse/?id=475
2010-01-04Santhera Presents New Data on MC-4R Antagonist Program for Treatment of Cancer Cachexia
http://www.hd-innovation.de/en/presse/?id=473
2009-12-07Phase III data of BF-200 ALA demonstrate superiority against Metvix®
http://www.hd-innovation.de/en/presse/?id=472
2009-12-02